vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and GREENE COUNTY BANCORP INC (GCBC). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $21.2M, roughly 1.0× Autolus Therapeutics plc). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -373.3%, a 419.6% gap on every dollar of revenue. GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
AUTL vs GCBC — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $21.2M | $22.2M |
| Net Profit | $-79.1M | $10.3M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 52.0% |
| Net Margin | -373.3% | 46.3% |
| Revenue YoY | — | 23.8% |
| Net Profit YoY | 3.6% | 37.4% |
| EPS (diluted) | $-0.30 | $0.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $22.2M | ||
| Q3 25 | $21.2M | $21.5M | ||
| Q2 25 | $20.9M | $20.5M | ||
| Q1 25 | $9.0M | $20.1M | ||
| Q4 24 | — | $17.9M | ||
| Q3 24 | $0 | $16.9M | ||
| Q2 24 | $0 | $16.6M | ||
| Q1 24 | $10.1M | $15.7M |
| Q4 25 | — | $10.3M | ||
| Q3 25 | $-79.1M | $8.9M | ||
| Q2 25 | $-47.9M | $9.3M | ||
| Q1 25 | $-70.2M | $8.1M | ||
| Q4 24 | — | $7.5M | ||
| Q3 24 | $-82.1M | $6.3M | ||
| Q2 24 | $-58.3M | $6.7M | ||
| Q1 24 | $-52.7M | $5.9M |
| Q4 25 | — | 52.0% | ||
| Q3 25 | -337.9% | 47.4% | ||
| Q2 25 | -292.6% | 53.5% | ||
| Q1 25 | -726.3% | 44.6% | ||
| Q4 24 | — | 45.0% | ||
| Q3 24 | — | 39.6% | ||
| Q2 24 | — | 41.2% | ||
| Q1 24 | -384.1% | 39.4% |
| Q4 25 | — | 46.3% | ||
| Q3 25 | -373.3% | 41.2% | ||
| Q2 25 | -229.0% | 45.6% | ||
| Q1 25 | -781.1% | 40.1% | ||
| Q4 24 | — | 41.7% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 40.6% | ||
| Q1 24 | -522.1% | 37.3% |
| Q4 25 | — | $0.60 | ||
| Q3 25 | $-0.30 | $0.52 | ||
| Q2 25 | $-0.18 | $0.55 | ||
| Q1 25 | $-0.26 | $0.47 | ||
| Q4 24 | — | $0.44 | ||
| Q3 24 | $-0.31 | $0.37 | ||
| Q2 24 | $-0.22 | $0.39 | ||
| Q1 24 | $-0.24 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $258.3M |
| Total Assets | $661.9M | $3.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | $155.5M | ||
| Q4 24 | — | $166.4M | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | $190.4M | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $258.3M | ||
| Q3 25 | $265.5M | $248.2M | ||
| Q2 25 | $346.5M | $238.8M | ||
| Q1 25 | $371.1M | $229.0M | ||
| Q4 24 | — | $218.4M | ||
| Q3 24 | $477.0M | $216.3M | ||
| Q2 24 | $527.8M | $206.0M | ||
| Q1 24 | $582.0M | $199.2M |
| Q4 25 | — | $3.1B | ||
| Q3 25 | $661.9M | $3.1B | ||
| Q2 25 | $721.0M | $3.0B | ||
| Q1 25 | $746.3M | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $827.5M | $2.9B | ||
| Q2 24 | $853.6M | $2.8B | ||
| Q1 24 | $901.4M | $2.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $6.4M |
| Free Cash FlowOCF − Capex | $-72.3M | $6.2M |
| FCF MarginFCF / Revenue | -341.2% | 28.0% |
| Capex IntensityCapex / Revenue | 20.8% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 0.62× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $47.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.4M | ||
| Q3 25 | $-67.9M | $7.0M | ||
| Q2 25 | $-72.8M | $28.0M | ||
| Q1 25 | $-75.6M | $7.3M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | $-76.7M | $2.1M | ||
| Q2 24 | $-51.1M | $24.9M | ||
| Q1 24 | $-40.5M | $5.6M |
| Q4 25 | — | $6.2M | ||
| Q3 25 | $-72.3M | $6.5M | ||
| Q2 25 | $-80.1M | $27.3M | ||
| Q1 25 | $-83.8M | $7.3M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $-86.3M | $2.0M | ||
| Q2 24 | $-51.9M | $23.4M | ||
| Q1 24 | $-41.0M | $4.9M |
| Q4 25 | — | 28.0% | ||
| Q3 25 | -341.2% | 30.4% | ||
| Q2 25 | -382.6% | 133.3% | ||
| Q1 25 | -933.1% | 36.1% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 141.2% | ||
| Q1 24 | -406.8% | 31.3% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 20.8% | 1.9% | ||
| Q2 25 | 34.8% | 3.4% | ||
| Q1 25 | 91.8% | 0.3% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | 5.3% | 4.2% |
| Q4 25 | — | 0.62× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 3.00× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.71× | ||
| Q3 24 | — | 0.34× | ||
| Q2 24 | — | 3.70× | ||
| Q1 24 | — | 0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.